All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YF259 | Anti-CD19×CD20 (FMC639×2H7) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | FMC639 | Mouse | scFv (CD19)-scFv (CD20)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF260 | Anti-CD19×CD20 (F7F52×F7F54) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF273 | Anti-CD19×CD20 (F7F52×F7F55) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF274 | Anti-CD19×CD20 (F7F59×F7F55) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | F7F59 | Mouse | scFv (CD19)-scFv (CD20)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF275 | Anti-CD19×CD20 (F7F52×F7F56) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF286 | Anti-CD19×CD20 (FMC639×2H7) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | FMC639 | Mouse | scFv (CD19)-scFv (CD20)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF287 | Anti-CD19×CD20 (F7F52×F7F54) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF300 | Anti-CD19×CD20 (F7F52×F7F55) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF301 | Anti-CD19×CD20 (F7F59×F7F55) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | F7F59 | Mouse | scFv (CD19)-scFv (CD20)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF302 | Anti-CD19×CD20 (F7F52×F7F56) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF313 | Anti-CD19×CD20 (FMC639×2H7) h(CD3ζ) TanCAR, pCDCAR1 | Human | FMC639 | Mouse | scFv (CD19)-scFv (CD20)-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF314 | Anti-CD19×CD20 (F7F52×F7F54) h(CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF327 | Anti-CD19×CD20 (F7F52×F7F55) h(CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF340 | Anti-CD19×CD20 (FMC639×2H7) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | FMC639 | Mouse | scFv (CD19)-scFv (CD20)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF341 | Anti-CD19×CD20 (F7F52×F7F54) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF354 | Anti-CD19×CD20 (F7F52×F7F55) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF355 | Anti-CD19×CD20 (F7F59×F7F55) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | F7F59 | Mouse | scFv (CD19)-scFv (CD20)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF356 | Anti-CD19×CD20 (F7F52×F7F56) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF367 | Anti-CD19×CD20 (FMC639×2H7) h(CD28-OX40-CD3ζ) TanCAR, pCDCAR1 | Human | FMC639 | Mouse | scFv (CD19)-scFv (CD20)-CD28-OX40-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF368 | Anti-CD19×CD20 (F7F52×F7F54) h(CD28-OX40-CD3ζ) TanCAR, pCDCAR1 | Human | F7F52 | Mouse | scFv (CD19)-scFv (CD20)-CD28-OX40-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION